Depreciation of Beam Therapeutics Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Beam Therapeutics Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Beam Therapeutics Inc. Depreciation for the quarter ending 31 Dec 2025 was $5,668,000, a 4.1% increase year-over-year.
  • Beam Therapeutics Inc. Depreciation for the twelve months ending 31 Dec 2025 was $22,294,000, a 1.7% increase year-over-year.
  • Beam Therapeutics Inc. annual Depreciation for 2025 was $22,294,000, a 1.7% increase from 2024.
  • Beam Therapeutics Inc. annual Depreciation for 2024 was $21,925,000, a 9.6% increase from 2023.
  • Beam Therapeutics Inc. annual Depreciation for 2023 was $20,012,000, a 42% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Beam Therapeutics Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $22,294,000 $5,668,000 +$225,000 +4.1% 01 Oct 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $22,069,000 $5,560,000 +$85,000 +1.6% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $21,984,000 $5,538,000 -$38,000 -0.68% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $22,022,000 $5,528,000 +$97,000 +1.8% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $21,925,000 $5,443,000 +$81,000 +1.5% 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $21,844,000 $5,475,000 +$288,000 +5.6% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $21,556,000 $5,576,000 +$760,000 +16% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $20,796,000 $5,431,000 +$784,000 +17% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $20,012,000 $5,362,000 +$1,418,000 +36% 01 Oct 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
Q3 2023 $18,594,000 $5,187,000 +$1,714,000 +49% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 $16,880,000 $4,816,000 +$1,398,000 +41% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $15,482,000 $4,647,000 +$1,385,000 +42% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $14,097,000 $3,944,000 +$1,410,000 +56% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q3 2022 $12,687,000 $3,473,000 +$1,798,000 +107% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $10,889,000 $3,418,000 +$1,824,000 +114% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $9,065,000 $3,262,000 +$1,864,000 +133% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $7,201,000 $2,534,000 +$1,262,000 +99% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q3 2021 $5,939,000 $1,675,000 +$457,000 +38% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $5,482,000 $1,594,000 +$449,000 +39% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $5,033,000 $1,398,000 +$298,000 +27% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $4,735,000 $1,272,000 +$270,000 +27% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $4,465,000 $1,218,000 +$310,000 +34% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 $4,155,000 $1,145,000 +$287,000 +33% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $3,868,000 $1,100,000 +$365,000 +50% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q4 2019 $3,503,000 $1,002,000 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $908,000 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $858,000 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $735,000 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1

Beam Therapeutics Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $22,294,000 +$369,000 +1.7% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $21,925,000 +$1,913,000 +9.6% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $20,012,000 +$5,915,000 +42% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $14,097,000 +$6,896,000 +96% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 $7,201,000 +$2,466,000 +52% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $4,735,000 +$1,232,000 +35% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $3,503,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.